Coronary Artery Calcification and Risk Stratification in Familial Hypercholesterolemia: Moving Forward But Not There Yet
- PMID: 34274280
- DOI: 10.1016/j.jcmg.2021.06.013
Coronary Artery Calcification and Risk Stratification in Familial Hypercholesterolemia: Moving Forward But Not There Yet
Keywords: atherosclerosis; coronary calcification; familial hypercholesterolemia; risk factors.
Conflict of interest statement
Funding Support and Author Disclosures Dr Santos is a recipient of a scholarship from the Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq) process number 303734/2018-3, Brazil; and has received honoraria related to consulting, research, and/or speaker activities from Abbott, Amgen, Aché, AstraZeneca, Esperion, Emergency Medical Service, Getz Pharma, Kowa, Libbs, Merck, Merck Sharp & Dohme, Novo Nordisk, Novartis, PTC Therapeutics, Pfizer, and Sanofi. Dr Shapiro has served on Scientific Advisory Boards with Alexion, Amgen, Esperion, and Novartis.
Comment on
-
The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia.JACC Cardiovasc Imaging. 2021 Dec;14(12):2414-2424. doi: 10.1016/j.jcmg.2021.06.011. Epub 2021 Jul 14. JACC Cardiovasc Imaging. 2021. PMID: 34274263
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
